1 Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002;13(9):2384-98.

CAS  Article  Google Scholar 

2 Takiar V, Caplan MJ. Polycystic kidney disease: pathogenesis and potential therapies. Biochim Biophys Acta. 2011;1812(10):1337-43.

CAS  Article  Google Scholar 

National Kidney F & Kidney D. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. (2013).

4 Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2011;7(10):556-66.

CAS  Article  Google Scholar 

5 Perrone RD, Mouksassi MS, Romero K, Czerwiec FS, Chapman AB, Gitomer BY, Torres VE, Miskulin DC, Broadbent S, Marier JF. Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic didney disease. Kidney Int Rep. 2017;2(3):442-450.

Article  Google Scholar 

Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354(20):2122–30.

Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, Hogan MC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE; CRISP Investigators. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160–72.

8 Bae KT, Grantham JJ. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010;6(2):96-106.

CAS  Article  Google Scholar 

9 Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441-6.

Article  Google Scholar 

10 Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563-77.

Article  Google Scholar 

11 Purkayastha S, Zhao Y, Wu J, Hu R, McGirr A, Singh S, Chang K, Huang RY, Zhang PJ, Silva A, Soulen MC, Stavropoulos SW, Zhang Z, Bai HX. Differentiation of low and high grade renal cell carcinoma on routine MRI with an externally validated automatic machine learning algorithm. Sci Rep. 2020;10(1):19503.

CAS  Article  Google Scholar 

12 Bai X, Huang Q, Zuo P, Zhang X, Yuan J, Zhang X, Wang M, Xu W, Ye H, Zhao J, Sun H, Shao B, Wang H. MRI radiomics-based nomogram for individualised prediction of synchronous distant metastasis in patients with clear cell renal cell carcinoma. Eur Radiol. 2021;31(2):1029-1042.

Article  Google Scholar 

Choi JW, Hu R, Zhao Y, Purkayastha S, Wu J, McGirr AJ, Stavropoulos SW, Silva AC, Soulen MC, Palmer MB, Zhang PJL, Zhu C, Ahn SH, Bai HX. Preoperative prediction of the stage, size, grade, and necrosis score in clear cell renal cell carcinoma using MRI-based radiomics. Abdom Radiol (NY). 2021 Jan 2.

Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ; CRISP Investigators. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2017 Nov;92(5):1206–1216.

15 Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2012;7(3):479-86.

CAS  Article  Google Scholar 

Bae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DP; HALT PKD Consortium. Expanded imaging classification of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2020 ;31(7):1640–1651.

17 Ng F, Kozarski R, Ganeshan B, Goh V. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol. 2013;82(2):342-8.

Article  Google Scholar 

18 Chapiro J, Duran R, Lin M, Schernthaner RE, Wang Z, Gorodetski B, Geschwind JF. Identifying staging markers for hepatocellular carcinoma before transarterial chemoembolization: comparison of three-dimensional quantitative versus non-three-dimensional imaging markers. Radiology. 2015;275(2):438-47.

Article  Google Scholar 

19 Kickingereder P, Götz M, Muschelli J, Wick A, Neuberger U, Shinohara RT, Sill M, Nowosielski M, Schlemmer HP, Radbruch A, Wick W, Bendszus M, Maier-Hein KH, Bonekamp D. Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin Cancer Res. 2016;22(23):5765-5771.

CAS  Article  Google Scholar 

Bae KT, Tao C, Zhu F, Bost JE, Chapman AB, Grantham JJ, Torres VE, Guay-Woodford LM, Meyers CM, Bennett WM; Consortium for Radiologic Imaging Studies Polycystic Kidney Disease. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin J Am Soc Nephrol. 2009;4(4):719–25.

21 Yang Y, Chen M, Zhou J, Lv J, Song S, Fu L, Chen J, Yang M, Mei C. Interactions between macrophages and cyst-Lining epithelial cells promote kidney cyst growth in pkd1-deficient mice. J Am Soc Nephrol. 2018;29(9):2310-2325.

CAS  Article  Google Scholar 

22 Zimmerman KA, Song CJ, Li Z, Lever JM, Crossman DK, Rains A, Aloria EJ, Gonzalez NM, Bassler JR, Zhou J, Crowley MR, Revell DZ, Yan Z, Shan D, Benveniste EN, George JF, Mrug M, Yoder BK. Tissue-resident macrophages promote renal cystic disease. J Am Soc Nephrol. 2019;30(10):1841-1856.

CAS  Article  Google Scholar 

23 Riyahi S, Dev H, Blumenfeld JD, Rennert H, Yin X, Attari H, Barash I, Chicos I, Bobb W, Donahue S, Prince MR. Hemorrhagic cysts and other MR biomarkers for predicting renal dysfunction progression in autosomal dominant polycystic kidney disease. J Magn Reson Imaging. 2021;53(2):564-576.

Article  Google Scholar 

Spithoven EM, van Gastel MD, Messchendorp AL, Casteleijn NF, Drenth JP, Gaillard CA, de Fijter JW, Meijer E, Peters DJ, Kappert P, Renken RJ, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium; DIPAK Consortium. Estimation of total kidney volume in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2015;66(5):792–801.

Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2007;2(1):112–20.

26 Tellman MW, Bahler CD, Shumate AM, Bacallao RL, Sundaram CP. Management of pain in autosomal dominant polycystic kidney disease and anatomy of renal innervation. J Urol. 2015;193(5):1470-8.

Article  Google Scholar 

Yu J, Li B, Xiang YZ, Qi TG, Jin XB, Xiong H. Should kidney volume be used as an indicator of surgical occasion for patients with autosomal dominant polycystic kidney disease? Medicine (Baltimore). 2018;97(27):e11445.

28 Iliuta IA, Shi B, Pourafkari M, Akbari P, Bruni G, Hsiao R, Stella SF, Khalili K, Shlomovitz E, Pei Y. Foam sclerotherapy for cyst volume reduction in autosomal dominant polycystic kidney disease: a prospective cohort study. Kidney Med. 2019;1(6):366-375.

Article  Google Scholar 

29 Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol. 2006 ;1(1):148-57.

Article  Google Scholar 

30 De Rechter S, Breysem L, Mekahli D. Is autosomal dominant polycystic kidney disease becoming a pediatric disorder? Front Pediatr. 2017 Dec 20;5:272.

Article  Google Scholar 

31 Ozkok A, Akpinar TS, Tufan F, Kanitez NA, Uysal M, Guzel M, Caliskan Y, Alisir S, Yazici H, Ecder T. Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol. 2013;17(3):345-51.

Article  Google Scholar 

Gansevoort RT, Meijer E, Chapman AB, Czerwiec FS, Devuyst O, Grantham JJ, Higashihara E, Krasa HB, Ouyang J, Perrone RD, Torres VE; TEMPO 3:4 Investigators. Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. Nephrol Dial Transplant. 2016 ;31(11):1887–1894.